HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

• María García-Álvarez ,

  Contributed equally to this work with: María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Luis Marín, Marcos González

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Miguel Alcoceba ,

  Contributed equally to this work with: María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Luis Marín, Marcos González

  Affiliations Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain, Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain, CIBERONC, Madrid, Spain

  ⨯
• Miriam López-Parra ,

  Contributed equally to this work with: María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Luis Marín, Marcos González

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Noemí Puig,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Alicia Antón,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Ana Balanzategui,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Isabel Prieto-Conde,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Cristina Jiménez,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• María E. Sarasquete,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• M. Carmen Chillón,

  Affiliations Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain, CIBERONC, Madrid, Spain

  ⨯
• María Laura Gutiérrez,

  Affiliation Cytometry Service-NUCLEUS, Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL) and IBSAL (University of Salamanca), Salamanca, Spain

  ⨯
• Rocío Corral,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• José María Alonso,

  Affiliation Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• José Antonio Queizán,

  Affiliation Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• Julia Vidán,

  Affiliation Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• Emilia Pardal,

  Affiliation Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• María Jesús Peñarrubia,

  Affiliation Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• José M. Bastida,

  Affiliation Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain

  ⨯
• Ramón García-Sanz ,

  * E-mail: rgarcias@usal.es

  Affiliations Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain, Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain

  ⨯
• Luis Marín ,

  Contributed equally to this work with: María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Luis Marín, Marcos González

  Affiliations Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain, CIBERONC, Madrid, Spain

  ⨯
•  [ ... ],
• Marcos González

  Contributed equally to this work with: María García-Álvarez, Miguel Alcoceba, Miriam López-Parra, Luis Marín, Marcos González

  Affiliations Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain, Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain, CIBERONC, Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]